Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics is a biotechnology company focused on discovering and developing precision medicines that target disease-causing proteins.
3
Funding Rounds
$223.5m
Money raised
Overview
Monte Rosa Therapeutics is a biotechnology company focused on discovering and developing precision medicines that target disease-causing proteins.
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Monte Rosa Therapeutics, Inc. has raised a total of $32.5m in funding over 3 rounds.
Key Insights:
- Monte Rose Therapeutics Series A round, May 2020: $32.5m
- Monte Rosa Therapeutics, Inc. Series C round, March 2021: $95m
- Monte Rosa Therapeutics, Inc. Series B round September 2020: $96m
Monte Rose Therapeutics Series A round, May 2020
$32.5m
Monte Rosa Therapeutics, Inc. Series B round September 2020
$96m
Monte Rosa Therapeutics, Inc. Series C round, March 2021
$95m
Industries
Monte Rosa Therapeutics, Inc. is active in the following industries: